nicardipine has been researched along with Bone Loss, Osteoclastic in 1 studies
Nicardipine: A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents.
nicardipine : A racemate comprising equimolar amounts of (R)- and (S)-nicardipine. It is a calcium channel blocker which is used to treat hypertension.
2-[benzyl(methyl)amino]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine substituted by a methyl, {2-[benzyl(methyl)amino]ethoxy}carbonyl, 3-nitrophenyl, methoxycarbonyl and methyl groups at positions 2, 3, 4, 5 and 6, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Before the treatment hyperparathyroidism (HPTH) was estimated on the basis of serum parathormone (PTH), and bone histomorphometry (osteoclastic resorption surfaces (ORS), and number of osteoclasts (NO]." | 1.28 | Parathyroid hormone and cardiovascular effects of dihydropyridines in chronic renal failure. ( Guerin, AP; London, GM; Marchais, SJ; Metivier, F; Safar, ME; Sassano, P, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guerin, AP | 1 |
| London, GM | 1 |
| Marchais, SJ | 1 |
| Metivier, F | 1 |
| Safar, ME | 1 |
| Sassano, P | 1 |
1 other study available for nicardipine and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Parathyroid hormone and cardiovascular effects of dihydropyridines in chronic renal failure.
Topics: Adult; Aged; Aged, 80 and over; Blood Pressure; Bone Resorption; Drug Administration Schedule; Femal | 1990 |